COVID-19: implications for immunosuppression in kidney disease and transplantation

Andreas Kronbichler; Philipp Gauckler; Martin Windpessl; Jae Il Shin; Vivekanand Jha; Brad H. Rovin; Rainer Oberbauer

doi:10.1038/s41581-020-0305-6

Chapter in a book2017

Maintenance Immunosuppression in Kidney Transplantation

Monica Cortinovis, Giuseppe Remuzzi, Norberto Perico

Article2020

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Behnood Bikdeli, Mahesh V. Madhavan, David Jiménez, Taylor Chuich, Isaac Dreyfus, Elissa Driggin, Caroline Der‐Nigoghossian, Walter Ageno, Mohammad Madjid, Yutao Guo, Liang Tang, Yu Hu, Jay Giri, Mary Cushman, I. Quéré, Evangelos Dimakakos, C. Michael Gibson, Giuseppe Lippi, Emmanuel J. Favaloro, Jawed Fareed, Joseph A. Caprini, Alfonso Tafur, John Burton, Dominic P. Francese, Elizabeth Wang, Anna Falanga, Claire McLintock, Beverley J. Hunt, Alex C. Spyropoulos, Geoffrey D. Barnes, John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Philippe Gabríel Steg, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monréal, Harlan M. Krumholz, Stavros Konstantinides, Jeffrey I. Weitz, Professor Gregory Lip

Article2017

COVID-19: implications for immunosuppression in kidney disease and transplantation

Discussion(0)

Related publications

Maintenance Immunosuppression in Kidney Transplantation

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

[Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].

Minimisation of immunosuppression in transplantation – Authors' reply

COVID-19: Implications for Physical Activity, Health Disparities, and Health Equity